• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

350 万人免疫缺陷和癌症与人类免疫缺陷病毒(HIV):南非艾滋病毒癌症匹配研究。

Immunodeficiency and Cancer in 3.5 Million People Living With Human Immunodeficiency Virus (HIV): The South African HIV Cancer Match Study.

机构信息

Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.

National Cancer Registry, National Health Laboratory Service, Johannesburg, South Africa.

出版信息

Clin Infect Dis. 2021 Aug 2;73(3):e735-e744. doi: 10.1093/cid/ciab087.

DOI:10.1093/cid/ciab087
PMID:33530095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8326558/
Abstract

BACKGROUND

We analyzed associations between immunodeficiency and cancer incidence in a nationwide cohort of people living with human immunodeficiency virus (HIV; PLWH) in South Africa.

METHODS

We used data from the South African HIV Cancer Match Study built on HIV-related laboratory measurements from the National Health Laboratory Services and cancer records from the National Cancer Registry. We evaluated associations between time-updated CD4 cell count and cancer incidence rates using Cox proportional hazards models. We reported adjusted hazard ratios (aHRs) over a grid of CD4 values and estimated the aHR per 100 CD4 cells/µL decrease.

RESULTS

Of 3 532 266 PLWH, 15 078 developed cancer. The most common cancers were cervical cancer (4150 cases), Kaposi sarcoma (2262 cases), and non-Hodgkin lymphoma (1060 cases). The association between lower CD4 cell count and higher cancer incidence rates was strongest for conjunctival cancer (aHR per 100 CD4 cells/µL decrease: 1.46; 95% confidence interval [CI], 1.38-1.54), Kaposi sarcoma (aHR, 1.23; 95% CI, 1.20-1.26), and non-Hodgkin lymphoma (aHR, 1.18; 95% CI, 1.14-1.22). Among infection-unrelated cancers, lower CD4 cell counts were associated with higher incidence rates of esophageal cancer (aHR, 1.06; 95% CI, 1.00-1.11) but not breast, lung, or prostate cancer.

CONCLUSIONS

Lower CD4 cell counts were associated with an increased risk of developing various infection-related cancers among PLWH. Reducing HIV-induced immunodeficiency may be a potent cancer-prevention strategy among PLWH in sub-Saharan Africa, a region heavily burdened by cancers attributable to infections.

摘要

背景

我们分析了在南非一个全国性的艾滋病毒感染者队列中,免疫缺陷与癌症发病率之间的关联。

方法

我们使用了南非艾滋病毒癌症匹配研究的数据,该研究基于国家卫生实验室服务的艾滋病毒相关实验室测量值和国家癌症登记处的癌症记录。我们使用 Cox 比例风险模型评估了时间更新的 CD4 细胞计数与癌症发病率之间的关联。我们报告了在 CD4 值网格上的调整后风险比 (aHR),并估计了每降低 100 CD4 细胞/µL 的 aHR。

结果

在 3532266 名艾滋病毒感染者中,有 15078 人患上了癌症。最常见的癌症是宫颈癌 (4150 例)、卡波西肉瘤 (2262 例) 和非霍奇金淋巴瘤 (1060 例)。较低的 CD4 细胞计数与较高的癌症发病率之间的关联最强的是结膜癌 (每降低 100 CD4 细胞/µL 的 aHR:1.46;95%置信区间 [CI],1.38-1.54)、卡波西肉瘤 (aHR,1.23;95% CI,1.20-1.26) 和非霍奇金淋巴瘤 (aHR,1.18;95% CI,1.14-1.22)。在与感染无关的癌症中,较低的 CD4 细胞计数与食管癌发病率升高相关 (aHR,1.06;95% CI,1.00-1.11),但与乳腺癌、肺癌或前列腺癌无关。

结论

在艾滋病毒感染者中,较低的 CD4 细胞计数与各种感染相关癌症的发病风险增加相关。在撒哈拉以南非洲这一感染相关癌症负担沉重的地区,降低艾滋病毒引起的免疫缺陷可能是艾滋病毒感染者的一种有效的癌症预防策略。

相似文献

1
Immunodeficiency and Cancer in 3.5 Million People Living With Human Immunodeficiency Virus (HIV): The South African HIV Cancer Match Study.350 万人免疫缺陷和癌症与人类免疫缺陷病毒(HIV):南非艾滋病毒癌症匹配研究。
Clin Infect Dis. 2021 Aug 2;73(3):e735-e744. doi: 10.1093/cid/ciab087.
2
Cancer risk in adolescents and young adults living with HIV in South Africa: a nationwide cohort study.南非艾滋病毒感染者青少年和年轻成人的癌症风险:一项全国性队列研究。
Lancet HIV. 2021 Oct;8(10):e614-e622. doi: 10.1016/S2352-3018(21)00158-2. Epub 2021 Sep 9.
3
Age and Cancer Incidence in 5.2 Million People With Human Immunodeficiency Virus (HIV): The South African HIV Cancer Match Study.年龄与 520 万人的人类免疫缺陷病毒(HIV)感染者中的癌症发病率:南非艾滋病毒癌症匹配研究。
Clin Infect Dis. 2023 Apr 17;76(8):1440-1448. doi: 10.1093/cid/ciac925.
4
CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies.CD4/CD8 比值与高效治疗人类免疫缺陷病毒(HIV)感染背景下卡波西肉瘤或非霍奇金淋巴瘤的风险:20 项欧洲队列研究的协作分析。
Clin Infect Dis. 2021 Jul 1;73(1):50-59. doi: 10.1093/cid/ciaa1137.
5
Cohort profile: the South African HIV Cancer Match (SAM) Study, a national population-based cohort.队列资料简介:南非艾滋病毒癌症匹配(SAM)研究,一项全国性基于人群的队列研究。
BMJ Open. 2022 Apr 11;12(4):e053460. doi: 10.1136/bmjopen-2021-053460.
6
Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study.跨越五大洲的人类免疫缺陷病毒阳性成年人卡波西肉瘤风险比较:一项多地区多队列研究。
Clin Infect Dis. 2017 Oct 15;65(8):1316-1326. doi: 10.1093/cid/cix480.
7
AIDS-related cancer and severity of immunosuppression in persons with AIDS.艾滋病相关癌症与艾滋病患者免疫抑制的严重程度
J Natl Cancer Inst. 2007 Jun 20;99(12):962-72. doi: 10.1093/jnci/djm010. Epub 2007 Jun 12.
8
Cancer Risk in Older Persons Living With Human Immunodeficiency Virus Infection in the United States.美国老年人类免疫缺陷病毒感染者的癌症风险。
Clin Infect Dis. 2018 Jun 18;67(1):50-57. doi: 10.1093/cid/ciy012.
9
Cervical cancer risk in women living with HIV across four continents: A multicohort study.四大洲 HIV 感染者的宫颈癌风险:一项多队列研究。
Int J Cancer. 2020 Feb 1;146(3):601-609. doi: 10.1002/ijc.32260. Epub 2019 Jun 19.
10
Predictors of All-Cause Mortality Among People With Human Immunodeficiency Virus (HIV) in a Prospective Cohort Study in East Africa and Nigeria.东非和尼日利亚前瞻性队列研究中 HIV 感染者全因死亡率的预测因素。
Clin Infect Dis. 2022 Sep 10;75(4):657-664. doi: 10.1093/cid/ciab995.

引用本文的文献

1
Lymphoma in Sub-Saharan Africa: a scoping review of the epidemiology, treatment challenges, and patient pathways.撒哈拉以南非洲地区的淋巴瘤:关于流行病学、治疗挑战及患者就医途径的范围综述
Cancer Causes Control. 2025 Mar;36(3):199-230. doi: 10.1007/s10552-024-01922-z. Epub 2024 Oct 17.
2
HPV-associated cancers among people living with HIV: nationwide population-based retrospective cohort study 2004-21 in Estonia.爱沙尼亚2004年至2021年基于全国人口的HIV感染者中HPV相关癌症回顾性队列研究
Eur J Public Health. 2024 Dec 1;34(6):1199-1204. doi: 10.1093/eurpub/ckae152.
3
Cancer in People with HIV.HIV 感染者中的癌症。
Infect Dis Clin North Am. 2024 Sep;38(3):531-557. doi: 10.1016/j.idc.2024.06.007.
4
The burden of non-communicable diseases among people living with HIV in Sub-Saharan Africa: a systematic review and meta-analysis.撒哈拉以南非洲地区艾滋病毒感染者的非传染性疾病负担:一项系统评价和荟萃分析。
EClinicalMedicine. 2023 Oct 5;65:102255. doi: 10.1016/j.eclinm.2023.102255. eCollection 2023 Nov.
5
State of the science and future directions for research on HIV and cancer: Summary of a joint workshop sponsored by IARC and NCI.艾滋病毒和癌症研究的科学现状和未来方向:国际癌症研究机构和美国国家癌症研究所联合主办的研讨会总结。
Int J Cancer. 2024 Feb 15;154(4):596-606. doi: 10.1002/ijc.34727. Epub 2023 Sep 15.
6
Gynaecologic and breast cancers in women living with HIV in South Africa: A record linkage study.南非 HIV 感染者中的妇科和乳腺癌:一项记录链接研究。
Int J Cancer. 2024 Jan 15;154(2):284-296. doi: 10.1002/ijc.34712. Epub 2023 Sep 8.
7
Decreasing incidence of conjunctival squamous cell carcinoma in people with HIV in South Africa.南非 HIV 感染者结膜鳞状细胞癌发病率下降。
J Natl Cancer Inst. 2023 Oct 9;115(10):1213-1219. doi: 10.1093/jnci/djad119.
8
Age and Cancer Incidence in 5.2 Million People With Human Immunodeficiency Virus (HIV): The South African HIV Cancer Match Study.年龄与 520 万人的人类免疫缺陷病毒(HIV)感染者中的癌症发病率:南非艾滋病毒癌症匹配研究。
Clin Infect Dis. 2023 Apr 17;76(8):1440-1448. doi: 10.1093/cid/ciac925.
9
Human papillomavirus-related neoplasia of the ocular adnexa.眼附属器人乳头瘤病毒相关性肿瘤。
Acta Ophthalmol. 2022 Oct;100 Suppl 272(Suppl 272):3-33. doi: 10.1111/aos.15244.
10
Effects of Exosomal Viral Components on the Tumor Microenvironment.外泌体病毒成分对肿瘤微环境的影响。
Cancers (Basel). 2022 Jul 21;14(14):3552. doi: 10.3390/cancers14143552.

本文引用的文献

1
Association of antiretroviral therapy with anal high-risk human papillomavirus, anal intraepithelial neoplasia, and anal cancer in people living with HIV: a systematic review and meta-analysis.抗逆转录病毒疗法与 HIV 感染者肛门高危型人乳头瘤病毒、肛门上皮内瘤变和肛门癌的关联:系统评价和荟萃分析。
Lancet HIV. 2020 Apr;7(4):e262-e278. doi: 10.1016/S2352-3018(19)30434-5. Epub 2020 Feb 25.
2
Cancer during HIV infection.癌症与 HIV 感染。
APMIS. 2020 Feb;128(2):121-128. doi: 10.1111/apm.13020. Epub 2020 Jan 28.
3
The burden of squamous cell carcinoma of the conjunctiva in Africa.非洲结膜鳞状细胞癌的负担。
Cancer Epidemiol. 2019 Aug;61:150-153. doi: 10.1016/j.canep.2019.06.007. Epub 2019 Jun 27.
4
Cancer in Africa 2018: The role of infections.《2018 年非洲癌症:感染的作用》
Int J Cancer. 2020 Apr 15;146(8):2089-2103. doi: 10.1002/ijc.32538. Epub 2019 Aug 2.
5
Association of Immunosuppression and Human Immunodeficiency Virus (HIV) Viremia With Anal Cancer Risk in Persons Living With HIV in the United States and Canada.免疫抑制和人类免疫缺陷病毒(HIV)病毒血症与美国和加拿大 HIV 感染者肛门癌风险的关联。
Clin Infect Dis. 2020 Mar 3;70(6):1176-1185. doi: 10.1093/cid/ciz329.
6
Risk and Predictors of Esophageal and Stomach Cancers in HIV-Infected Veterans: A Matched Cohort Study.HIV 感染退伍军人的食管和胃癌风险及预测因素:一项匹配队列研究。
J Acquir Immune Defic Syndr. 2019 Jul 1;81(3):e65-e72. doi: 10.1097/QAI.0000000000002038.
7
Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study.加拿大和美国的艾滋病毒感染者中非霍奇金淋巴瘤发病风险的整体及亚型与免疫抑制和 HIV 病毒血症的相关性:一项多中心队列研究。
Lancet HIV. 2019 Apr;6(4):e240-e249. doi: 10.1016/S2352-3018(18)30360-6. Epub 2019 Feb 27.
8
Evidence of synergistic relationships between HIV and Human Papillomavirus (HPV): systematic reviews and meta-analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status.HIV 和人乳头瘤病毒(HPV)之间协同关系的证据:基于 HIV 状态的 HPV 获得和清除以及 HPV 状态与 HIV 获得的纵向研究的系统评价和荟萃分析。
J Int AIDS Soc. 2018 Jun;21(6):e25110. doi: 10.1002/jia2.25110.
9
Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada.简报:美国和加拿大 HIV 感染者的皮肤黑色素瘤风险。
J Acquir Immune Defic Syndr. 2018 Aug 15;78(5):499-504. doi: 10.1097/QAI.0000000000001719.
10
Risk of Breast, Prostate, and Colorectal Cancer Diagnoses Among HIV-Infected Individuals in the United States.美国 HIV 感染者的乳腺癌、前列腺癌和结直肠癌诊断风险。
J Natl Cancer Inst. 2018 Sep 1;110(9):959-966. doi: 10.1093/jnci/djy010.